| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2358 |
| Trial ID | NCT04404660 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AUTO1|Obecabtagene autoleucel|obe-cel |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) |
| Year | 2020 |
| Country | United States |
| Company sponsor | Autolus Limited |
| Other ID(s) | FELIX (AUTO1-AL1)|2019-001937-16 |
| Cohort 1 | |||||||||||||
|
|||||||||||||